We are trying to confirm that report. It is not possible to predict whether colon cancer will respond to this drug, explained Dr. Ibrahim Sbeitan, medical director of the Conemaugh Center for Cancer Care. It is not clear at this time which of the treatments in this program would be better, he added. For this reason, the treatment plan offered to each patient will be chosen by a method called randomization, by chance. The chances of receiving either of the treatments are approximately equal.
Colorectal cancers are the third most common cancers among men and women.
An estimated 56,300 Americans will die as a result of colorectal cancer in 2000, accounting for approximately 11 percent of cancer deaths. Symptoms of colorectal cancer may include rectal bleeding, blood in the stool, or a change in bowel habits. If you experience any of these symptoms, you should seek the advice of a medical professional. All Rights Reserved. Please view our Disclaimer and Privacy Statement .